What is Eton Pharmaceuticals, Inc.'s free cash flow yield?

Eton Pharmaceuticals, Inc. (ETON) reported free cash flow yield of 6.1% in Q1 2024.

What does free cash flow yield mean?

Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.

Eton Pharmaceuticals, Inc. ETON Free cash flow yield

Free cash flow yield at other companies

HRO

HarrowHROW

1.2%+1.0pp

Zevra Therapeutics, Inc.ZVRA

-9.3%-3.7pp

Ultragenyx PharmaceuticalRARE

-24.4%-252pp

ANI PharmaceuticalsANIP

11.1%+6.5pp

Crinetics PharmaceuticalsCRNX

-11%+4.2pp

Catalyst PharmaceuticalCPRX

6.9%-2.2pp

Other financials

Income statement

See full

Revenue$24.3M+40.4%

Gross profit$14.7M+49.4%

Operating income$2.4M+614%

Net income$1.6M+199%

EPS (diluted)$0.05+183%

Balance sheet

See full

Cash & equivalents$19.7M+12.9%

Total debt$31.3M+3.7%

Total equity$30.6M+25.2%

Total assets$97.7M+16.3%

Cash flow

See full

Operating cash flow$7.4M+254%

CapEx$75.0K—

Free cash flow$7.3M+251%

Valuation

See full

Market cap$930.79M+162%

Enterprise value$942.39M+156%

P/S10.7×+3.4×

Profitability

See full

Gross margin54.8%-3.7pp

Operating margin-15.1%—

Net margin-9.5%-2.7pp

FCF margin17.1%—

Returns & leverage

See full

Return on equity-34.2%+0.9pp

Debt / equity1×-0.2×

Current ratio1.2×-0.8×

Where this comes from

Calculated from Eton Pharmaceuticals, Inc.’s reported figures.

free cash flow/market cap=6.1%

Based on trailing twelve months.

The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 9, 2024, on SEC EDGAR. View the filing →

Ask your AI about Eton Pharmaceuticals, Inc.'s free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Eton Pharmaceuticals, Inc.'s free cash flow yield?: Eton Pharmaceuticals, Inc. (ETON) reported free cash flow yield of 6.1% in Q1 2024.
What does free cash flow yield mean?: Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.